These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Clinical importance of determining the digoxin level in the serum in long-term beta-methyldigoxin treatment]. Author: Todorova R, Baltadzhieva D, Staneva D. Journal: Vutr Boles; 1987; 26(6):26-9. PubMed ID: 3439149. Abstract: The digoxin level was determined by radioimmunologic method in 54 patients with cardiac failure on constant maintaining glycoside treatment with beta-methyldigoxin in doses of 0.7-0.1, 4 mg weekly. The results showed that: Between the maintaining dose of Beta-Methyldigoxin and the serum digoxin level there is not always parallelism in cases of achieved cardiac compensation. In spite of that the achievement of cardiac compensation and its maintainance in more than 85% of the cases is possible with a mean dose of Lanitop 1.0 mg weekly and digoxin serum level between 1.0 and 2.0 ng/ml. Between the toxic manifestations observed and the doses applied there is not a strong correlation. But the high digoxin levels are always potentially toxic.[Abstract] [Full Text] [Related] [New Search]